Nick Pappas

Capital Markets

• Advised public and private companies in connection with public and private capital markets transactions, including initial public offerings, secondary offerings, block trades, PIPE transactions, Rule 144 sales, and high-yield and investment grade debt offerings (including registered, Rule 144A and Regulation S offerings).
• Represented leading global security products and solutions provider on its offering of $400 million of 5.600% senior notes due 2034.
• Represented cleaning product company in its offering of $500 million of 4.625% senior notes due 2029.
• Represented leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment in its follow-on offering of $125 million of its ordinary shares.
• Represented private equity firm in multiple secondary offerings totaling over $3 billion.
• Represented private equity firm in the preferred financing component of its acquisition of a majority stake in a payment processing company in a transaction that valued the business at $18.5 billion.
• Represented a portfolio company of a private equity firm in its issuance of $80 million of preferred equity.
• Represented aerospace manufacturer and space infrastructure technology company in its issuance of $80 million of Series A Convertible Preferred Stock, as well as in its $80 million committed equity facility.

Mergers & Acquisitions

• Represented educational technology company in its acquisition of world's largest academic credential management platform and network for $835 million.
• Represented cleaning product company and private investment firm on the former's $4.6 billion sale.
• Represented private equity firm and aerospace manufacturer in the latter's business combination with a special purpose acquisition company, resulting in the manufacturer's listing on the NYSE.
• Represented revenue cycle management company in its acquisition of a leader in revenue intelligence solutions for healthcare providers for $4.1 billion.
• Represented aerospace manufacturer in its acquisition of Belgium-based commercial space business.
• Represented aerospace manufacturer in its acquisition of a leader in biotechnology in microgravity, bioprinting, and on-orbit manufacturing needed for commercial space-based research and development.
• Represented private equity firm in its acquisition of a leader in revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators for approximately $1.25 billion.
• Represented private equity firm in numerous transactions, including the following:
  • acquisition of a leader in data integration and data integrity for approximately $2.4 billion.
  • acquisition of a leader in video-based human insight for approximately $1.3 billion.
  • acquisition of a leader in Business Spend Management for approximately $8.0 billion.
  • acquisition of a global leader in critical event management and national public warning solutions for approximately $1.8 billion.
  • sale of educational technology company for approximately $4.8 billion.
  • sale of privately held cybersecurity company for an enterprise value of approximately $1.54 billion in a combination of cash and purchaser shares.
• Represented online dealer-to-dealer vehicle wholesaling platform in its $450 million sale.

Restructuring Matters

• Represented a private investment firm in its restructuring of existing debt and simultaneous issuance of preferred equity to certain debt holders.
• Represented a private provider of SaaS and cloud-based remote work tools in its restructuring of existing outstanding term loans and senior notes, including the issuance of new senior notes.

Securities Matters

• Drafted and reviewed press releases and various SEC filings, including Forms 10-K, 10-Q and 8-K, proxy statements, and Section 13 and Section 16 filings.
• Counseled issuers in connection with initial listings on the New York Stock Exchange (NYSE) and the Nasdaq Stock Market (NASDAQ) and on U.S. securities laws and exchange listing rules, including compliance with exchange listing requirements, Sarbanes-Oxley, Regulation FD, preparation of proxy statements and materials, organization of stockholder meetings and related interactions with proxy advisors, delisting/deregistration, SEC and FINRA inquiries, director independence, issuer repurchases, insider trading and preparation, and review of organizational documents and governance policies.